← Leaderboards
Tarek Ziad Deeb
Tufts University Boston
$1,404,096
Attributed
$2,560,691
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $704.7K · FY2017–21$1M$750K$500K$250K$0
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$2,560,691 · 2
By mechanism
R01$2,313,191 · 1
R21$247,500 · 1
Top collaborators
- Stephen J Moss5 shared
Most similar at Tufts University Boston
Same institution · by research overlap
- Daniel G. Jay$9,101,895
- Margery C Beinfeld$1,915,714
- Peter A Bullock$4,067,693
- Paul Andrew Davies$3,367,637
Others in their field
Other Emerging Leaders on “Mutant”
- Timothy M Willson · University Of Cape Town$12,760,250
- Jacqueline K White · Jackson Laboratory$12,159,072
- Timothy Yikai Huang · Sanford Burnham Prebys Medical Discovery Institute$9,169,050
- Kristen A Johnson · California Institute/Biomedical Research$8,530,970
- Frederic Geissmann · Sloan-Kettering Inst Can Research$7,125,954
- John Damon Chodera · Sloan-Kettering Inst Can Research$6,599,276
Research focus
MutantNeuronsMediatingModificationMutationNeuronal ExcitabilityIon ChannelMaintenanceMembrane PotentialsExhibitsImpairmentBrainGeneticGamma-Aminobutyric AcidAdultInsightCellsCell SurfaceEpilepsyMembraneEquilibriumEventHippocampus (Brain)Permeability
Grant awards (6)
Modulation of KCC2 activity and the postnatal development of synaptic inhibition$457,238
R01 · FY2021 · NS
Modulation of KCC2 activity and the postnatal development of synaptic inhibition$457,238
R01 · FY2020 · NS
Modulation of KCC2 activity and the postnatal development of synaptic inhibition$457,238
R01 · FY2019 · NS
Determining the effects of human KCC2 mutations on neuronal excitability$247,500
R21 · FY2019 · NS · contact PI
Modulation of KCC2 activity and the postnatal development of synaptic inhibition$457,238
R01 · FY2018 · NS
Modulation of KCC2 activity and the postnatal development of synaptic inhibition$484,239
R01 · FY2017 · NS